Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ondansetron Augmentation in Treatment-resistant OCD

NCT01303536 is registered in ClinicalTrials.gov with Institute of Neuroscience, Florence, Italy as lead sponsor.

NCT NCT01303536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01303536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ondansetron Augmentation in Treatment-resistant OCD
Lead sponsor
Institute of Neuroscience, Florence, Italy
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2009
Completion date
March 31, 2010
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obsessive compulsive disorder